FDA
label_change
· 2017-08-01
FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
Summary
FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories to update the product labeling with expanded indications.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LUBIPROSTONE (LUBIPROSTONE)